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osting by EAbstract Taxol is a microtubule inhibitor drug widely used in treatment of many types of can-
cer. Nephrotoxicity is the most hazardous effect complicating chemotherapy in general and kid-
ney functions must be monitored early during any chemotherapeutic course. The main objective
of the present study was to investigate the effect of acute Taxol nephrotoxicity in mice. In the
present study Taxol at different doses; MD, ID and MTD (0.6, 1.15 and 1.7 mg/kg), respec-
tively, was given by intra-peritoneal route to 54 adult male mice with an average body weight
of 20–25 g. Kidney samples was taken 6, 24, 48 h following administration, ﬁxed in 10% neutral
buffered formalin, parafﬁn sections 5 lm thick were stained by haematoxylin and eosin and PAS
and then examined for histological changes. Samples from animals treated by the maximum
dose (MTD= 1.7 mg/kg) for 48 h were ﬁxed in 3% gluteraldehyde in phosphate buffer (pH
7.4) and processed for transmission electron microscope. Taxol given for short duration was
found to produce marked degenerative changes in kidney parenchyma even in minimum toler-
ated dose (MD= 0.6 mg/kg). Individual variations were observed regarding the degree of neph-
rotoxicity. There was marked loss of renal tubules epithelial lining, damage of brush border and
formation of hyaline casts within the damaged tubules. The alterations were in the form of both
necrotic and apoptotic changes in the kidney tubules. Focal atrophy of glomerular tufts was
also observed. Vascular congestion and degenerative changes in renal blood vessels were occa-
sionally evident in some samples. Ultrastructure study revealed damage of glomerular mem-
brane. Proximal tubule showed loss of basal infoldings, damage of brush border,
mitochondrial degeneration and nuclear changes. Distal tubules also showed demarked degener-
ative changes. Increased frequency of micronuclei proved that Taxol had genotoxic effects inity. All rights reserved. Peer-
d University.
lsevier
106 S.O. Rabahmice bone marrow cells. In conclusion Taxol had nephrotoxic effect on mice kidney that must
be considered during its use as a chemotherapeutic agent in human.
ª 2010 King Saud University. All rights reserved.1. Introduction
Most cytotoxic drugs including Taxol interact directly with
DNA or its precursors, inhibiting the synthesis of new genetic
material or causing irreparable damage to DNA (Zhou et al.,
2003). Although anticancer or cytotoxic drugs are advanta-
geous in treating cancer, they also have their drawbacks.
One of the greatest problems is that cytotoxic drugs may not
distinguish between normal and cancer cells. Unfortunately,
no currently available agent meets this criterion (Damia and
Broggini, 2004).
Therefore, normal tissues that have higher rates of cellular
proliferations such as bone marrow and reproductive organs
are very susceptible to anticancer drugs. Liver and kidney
are the most sensitive organs for chemotherapy cytotoxicity
(Merouani et al., 1997).
Taxol is a new anticancer drug that is isolated from stem
park of the paciﬁc yew tree; Taxus brevifolia. Its antitumour
activity against a variety of rodent tumors was discovered in
1967; when, its unique mechanism of action led to the develop-
ment of a new class of chemotherapeutic agents called taxanes
(). In 1991, The National Cancer Institute hailed Taxol (also
known as paclitaxel) as the most important new cancer drug
in the past 15 years, and it has recently been called the best
new anticancer agent developed from natural agents. Although
the drug was discovered forty years ago, it was not tested
experimentally until 1977. It took another sixteen years to be
approved by the Food and Drug Administration (FDA) for
the treatment of ovarian cancer, breast cancer, and Kaposi’s
sarcoma. It has been shown to be effective against solid tu-
mors, breast, lung and colorectal cancers, which before were
unaffected by most chemotherapeutic agents (Kubota et al.,
1997). Taxol can either be used on its own as monotherapy
or in combination with other drugs (Kolomeichuk et al.,
2008). Taxol, when used on its own, produced a response in
up to 60% of patients with breast and ovarian cancer (Tre-
sukosol et al., 1995). It has been described to have some activ-
ity in head and neck gastric cancer, and hematological cancer
(Crown and O’Leary, 2000). Paclitaxel (Taxol) prevents cell
division by promoting the assembly of stable microtubules
from a and b tubulin heterodimers and inhibiting their depoly-
merisation (Schiff and Horwitz, 1981). This is an opposite ef-
fect to the Vince alkaloids, which inhibit the polymerization
of the microtubules (Goodsell, 2000). Taxol has been reported
to induce micronuclei (Bajie et al., 2007). Moreover, investiga-
tions have shown that Taxol activates a checkpoint pathway
that delays cell cycle progression and induces programmed cell
death (Sorger et al., 1997; Guo et al., 2002; Ikui et al., 2005).
Nephrotoxicity of Taxol was reported with other cytotoxic
drugs. However, no available literatures dealing with histolog-
ical changes in kidney parenchyma evoked by Taxol adminis-
tration. In the present study, acute Taxol nephrotoxicity at 3
different doses was tested. Light and electron microscopic
studies were used to demonstrate cytotoxicity. Micronuclei as-say was applied for testing aneuogenecity that may delay cell
cycle program or induced programmed cell death (Jagetia
and Adiga, 1997).
1.1. Histological studies
1.1.1. Animal preparation
Fifty-four adult male albino mice (average weight 25–30 g)
were obtained from King Fahad medical research centre King
Abdel Aziz University. The animals were divided into two
groups; control (n= 9) and experimental (n= 45). The later
was sub divided into three subgroups, G1, G2 and G3 each
15 animals for the three used doses.
The drug was dissolved in normal saline and given as a sin-
gle dose to G1, G2 and G3, respectively, via intra-peritoneal
route at three different doses; maximum tolerated dose
(MTD), intermediate dose (ID) and a medical dose (MD)
(1.7, 1.15 and 0.6 mg/kg), respectively.
The control group was injected with 0.9% ml saline only.
The animals were dissected after 6, 24, and 48 h following
injection. The heart was perfused by normal saline followed
by 10% neutral buffered formalin to insure perfect ﬁxation.
The Kidneys were removed; 2–3 mm specimens from each were
reﬁxed in the same ﬁxative for 12, 24 h, dehydrated using the
ascending grades of alcohol (70–100%) for 1–2 h and cleared
in xylene. The specimens were embedded in parafﬁn at
58 C, then sections of 5–7 lm thick and stained by haematox-
ylin and eosin and periodic acid schief (PAS) for further exam-
ination and photographing using light microscopic provided
by digital camera connected to computer.
For electron microscopy small pieces (2 mm) from control
and Taxol treated mice kidney were ﬁxed in 2.5% gluteralde-
hyde in 0.1 m phosphate buffer (pH 7.3) for 30 min, 1% os-
mium tetraoxide in 0.1 M phosphate buffer (pH 7.3) for 1 h.
The specimens was washed twice by 0.1 m phosphate buffer
for 5 min each, the samples was immersed in propylene oxide
(two changes) then in a mixture of propylene oxide and resin
and embedded in (Epon). Ultra thin section, 80–100 A˚ thick
were cut by glass knife and examined by using EM.
1.2. Micronucleus assay
Bone marrow samples from animals at the three used doses
(MTD, ID and MD) were used for scoring the number of
micronuclei in polychromatic erythrocyte (PCE) is performed
according to the method described by Matter and Schmid
(1971). With some modiﬁcations by Hedle et al. (1984). As fol-
lows; mice were sacriﬁced by cervical dislocation at appropri-
ate sample time, and the femurs were removed. The bone
marrow was pushed out with a pin, placed on a microscope
slide, and mixed with drop of fetal calf serum. The cells were
then smeared and allowed to dry. The slides were ﬁxed in abso-
lute methanol and stained with Giemsa stain. One thousand
polychromatic erythrocytes (PCEs) were scored, and the num-
Figure 2 Section in control mice kidney showing arcute artery at
cortico-medullary junction (H· and E· 400).
Figure 3 Section of kidney of Taxol treated mice (0.6 mg-24 h)
showing wide spacing (star) of tubules with atrophy of their lining
epithelium. Notice the reticulated casts within their lumumina
(arrows). There is marked atrophy of renal corpuscle (black
arrow) (H· and E· 400).
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identiﬁed as dark staining rounded bodies in cytoplasm of
PCE. Five-thousand cells per each treatment dose will be
examined to score the number of micronuclei in PCEs. Precau-
tions with regard to scoring and artifacts were taken as de-
scribed by Hedle et al. (1984).
2. Results
Animals injected by Taxol become aggressive immediately
after injection then looked weak and unable to move com-
pared to control. Although animals lost their appetite to food.
Animal weight was not signiﬁcantly affected owing to short
duration of Taxol administration.
2.1. Effect of acute Taxol administration on mice kidney
parenchyma
2.1.1. Light microscopic study
2.1.1.1. Control mice. The histology of control mice renal
parenchyma was normal and was similar to those described
in previous literature regarding mammalian kidney including
mice (Figs. 1 and 2).
2.1.1.2. Histological change of kidney parenchyma in mice after
24–48 h of treatment by Taxol (0.6 mg/kg/BW). Histological
examination of Taxol treated kidney (24 h by 0.6 mg) revealed
degenerative changes in most parenchymatous elements in
comparison with control. The changes were more evident at
48 h. Atrophy of renal corpuscle and, decrease in glomerular
cellularity was observed. There was wide spacing of tubules,
atrophy of the lining epithelium and reticulated casts within
the lumen. Proximal tubules showed histological changes in
the form of widening of tubular lumen and vaculation of some
of the lining cells. Marked atrophy and degeneration of distal
tubules cells was also observed (Fig. 3). The arcute vessels were
dilated and showed degeneration of their vascular wall. There
was also perivascular edema and ﬁbrosis (Fig. 4).
2.1.1.3. Histological change of kidney parenchyma in mice after
24–48 h of treatment by Taxol 1.15 mg/kg/BW. The kidney ofFigure 1 Section in control mice kidney showing normal
glomeruls (G), proximal (PT) and distal (DT) tubules (H· and
E· 400).
Figure 4 Section in mice kidney of Taxol treated mice (1.15 mg/
kg) showing atrophy and degeneration of renal tubules (thin
arrows), thickened arterial wall (thick arrows), and perivascular
edema and ﬁbrosis (stars).mice receiving 1.5 mg/kg Taxol for 24 h showed marked con-
gestion of renal veins in the cortical regions (Fig. 5). Both
proximal and distal tubules showed disorganization and
Figure 5 Section of Taxol treated mice kidney 24 h after 1.15 g
Taxol administration showing vascular congestion (red arrow)
together with atrophy of both renal corpuscle and tubular
epithelium (black arrow).
Figure 6 Section of Taxol treated mice kidney showing widened
deformed renal tubules with intraluminal casts (thin arrow) the
arcute artery (A) showing thick degenerated wall (H· and E· 400).
Figure 7 Section of mice kidney treated with 1.7 mg taxol after
48h showing disorganization and degeneration of tubules. The
cytoplasm stained dark red and nuclei are small and dark
(arrows).
Figure 8 Section in Taxol treated kidney showing widening of
tubular lumen due to atrophy and vaculation of the lining
epithelium and appearance of casts within the lumen (arrows).
Notice the marked dilated vein (star).
Figures 9 and 10 Section of Taxol treated mouse kidney showing
marked apoptotic changes (thin arrows) of proximal tubules is
observed 48 h following 1.7 mg/kg. The lining cells are highly
acidophilic, the nuclei are small or pyknotic and deeply stained.
108 S.O. Rabahdegenerated epithelial lining. The cells showed decrease in
height, the cytoplasm stained dark acidophilic, and the nucleiare small, pyknotic and dark stained. Collecting distal tubules
showed wide lumina. Renal vessels showed thickening with
degeneration of wall components (Fig. 6).
Occasionally sever vacuolar degeneration of tubular lining
epithelium or apoptotic changes (dark stained cells with small
Figure 11 Section of Taxol treated mouse kidney showing
marked disorganization of renal tubules with necrotic (arrow) or
apoptotic changes (thick arrow), glomerular atrophy is also
evident (thick arrow).
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lar dilatation and intraluminal casts were observed in the tu-
bules adjacent to renal medulla (Fig. 8).
2.1.1.4. Histological change of kidney parenchyma in mice after
24–48 h of treatment by Taxol 1.7 mg/kg/BW. After 24 h the
kidney of mice receiving 1.7 mg of Taxol showed both necrotic
and apoptotic changes in the renal tubules; focal apoptotic
changes involve proximal tubules were observed. The tubules
showed hyaline staining; the cytoplasm was stained deeply aci-
dophilic. The nuclei were small and deeply stained (pyknotic)
(Figs. 9 and 10). Occasionally there was marked loss of normal
kidney parenchymatous organizations (Fig. 11). There was
also hyaline degeneration or apoptosis of most tubules. Distal
tubules showed unstained cells with dark stain nuclei. The
changes were more severe after 48 h where there was a large re-
gion of complete necrosis of both parenchyma and vascular
elements. Cell debris and blood cells were observed in the ne-
crotic regions (Fig. 12). The tubules had dilated lumina and
contain hyaline casts. Marked atrophy of glomerular tufts
was observed (Fig. 13). The renal vessels at cortico-medullary
junction showed massive degeneration of vascular elements
and perivascular edema (Fig. 14).
2.1.2. Histochemical alterations
PAS +ve material was observed in the basement membrane of
Bowman capsule and renal tubules. The brush border of prox-
imal tubules (PT) lining cells showed highly PAS positive stain-
ing (Fig. 15).In Taxol treated kidney there was a decrease in PAS +ve
staining of the basement membrane of altered renal tubules
and Bowman capsule. Loss of brush border staining in dilated
PT was also observed (Fig. 16).
2.2. Ultrastructure alteration
Figs. 17–19 shows the semi-thin sections of parts of both con-
trol and Taxol (1.7 mg/kg for 48 h) treated mice kidney from
which ultra thin sections were prepared for ultra structure
studies.
Taxol treated kidney in a dose of 1.7 mg/kg for 48 h showed
focalatrophy and shrinkage of renal corpuscles, glomeruli and
tubules (Fig. 18) compared to control (Fig. 17). In some sam-
ples massive necrosis and loss or renal elements was observed
(Fig. 19).
The ultrastructure study of control mice kidney showed
normal appearance as described in previous literature. The re-
nal cortex contains renal corpuscles surrounded by renal tu-
bules (proximal and distal). Glomerular capillaries have
fenestrated endothelium, thin basement membrane. Podocytes
have with large vesicular nuclei. Their processes were seen end-
ing on glomerular capillary the basement membrane (Fig. 18).
Ultrastructure showed the degenerative changes in podo-
cyte lining the visceral layer of bowman capsule the cells had
thin processes and dark or vacuolated cytoplasm (Fig. 19).
The proximal tubule (PCT) in control mice is lined by
cuboidal cells showing apical microvillus, and dense bodies,
most probably proteins. The nucleus (N) is large, vesicular
with well deﬁned nucleolus. Basal mitochondria (M) were lo-
cated between basal enfolding. The basement membrane is reg-
ular and of normal thickness (Fig. 20). In Taxol treated
animals, PCT showing destruction of apical microvillus (white
arrow) the nucleus (N) showed irregular shape and abnormal
distribution of peripheral chromatin (star) and nucleolus
(NU). Basal enfolding enclosed abnormal dark stained mito-
chondria (M) surrounded by light spaces. The basement mem-
brane (BM) is irregular and thickened (Fig. 21).
Distal convoluted tubule (DCT) of control mice kidney
showing normal thickness basement membrane (BM), basal
infolding and mitochondria (M). The nucleus is large with nor-
mal peripheral chromatin distribution. The lumen (L) is
bounded by the apical cellular membrane having few microvilli
(Fig. 22). DCT lining cell from mice treated with (1.7 mg) Tax-
ol showed thickened basement membrane (BM). Dark degen-
erated mitochondria (M) among abnormal basal folding. The
nucleus showed chromatin clumps (Fig. 23).
2.3. Micronuclei formation
Micronucleus formation was known as a test for cytotoxicity.
In the present study, 6 h treatment did not modify the number
of micro-nucleated polychromatic erythrocytes ‘‘MN-PCEs’’
in samples analyzed. On the other hand, the frequencies of
‘‘MN-PCEs’’ were signiﬁcantly higher in the treated mice at
24 and 48 h with all doses. Table 1 is compared to control.
3. Discussion
Taxol, was shown to have anticancer effect in the early 1960s,
where it interferes with cell division by binding to the protein
Figures 12–14 Section from mouse kidney after 48 h the kidney of mice receiving 1.7 mg/kg of Taxol showing massive regions of
necrosis with complete loss (star) of renal parenchyma. The rest of tubules showed dilated (arrow) or dilated and contain hyaline.
Figure 15 Parafﬁn section of control mouse kidney showing
high (PAS +ve) reaction in the basement membrane of Bowman
capsule and renal tubules. The brush border of proximal tubule
epithelial cells is highly PAS +ve (arrow).
Figure 16 Section of mouse kidney after48 h of Taxol injection
(1.7 mg/kg) showing loss of PAS +ve reaction in regions
described in control due to damage of brush border of most
tubules. The basement membrane is also is ill deﬁned.
110 S.O. Rabahtubulin, which is a key factor in mitosis, the process of cell
division and growth (Jordan et al., 1993). This could affectregenerative activity of many organs including renal paren-
chyma. Since, Taxol has so been proven to be effective for
Figure 17 Semithin section from control mice kidney showing
normal renal corpuscle and glomerulus (star), proximal (PT) and
distal (DT) tubules. Toluidine blue ·400.
Figure 18 Semithin section from Taxol (1.7 mg for 48 h) treated
kidney showing atrophy of a renal corpuscle and glomerulus
(star), shrinked degenerated proximal tubules (black arrow) and
damaged distal tubules (double head arrow). Toluidine blue ·100.
Figure 19 Semi thin section of Taxol (1.7 mg for 48 h) treated
kidney showing marked degeneration (arrows) and necrosis of
renal elements. Only ghosts of tubules and corpuscles are seen
(stars).
Figure 20 Electron micrograph of part of kidney in control
mouse, showing part of a glomerulus, two podocytes (1, 2) with
large vesicular nuclei (N) were observed. Notice that the foot
processes ending on glomerular capillary surface. Electrograph of
a magniﬁed proximal convoluted tubule (PCT) cell of control
mouse showing apical microvilli (mv) and dense bodies. The
nucleus (N) is large, vesicular with well deﬁned nucleolus.
Mitochondria (M) were located between basal infolding. The
basement membrane is regular and of normal thickness (thin
arrow).
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is recently introduced into Kingdom of Saudi Arabia, its effect
on renal functions and structure seemed to be of great clinicalimportance. The only study regarding nephrotoxicity was that
of Merouani et al. (1997), who did a retrospective analysis of
renal function in patients with gynecological cancers and
found an increased nephrotoxicity in patients treated with
Taxol and cisplatin as compared to cisplatin alone. However,
literature in histological changes was unavailable. The present
results could be considered preliminary in that subject.
In the present study, it was observed that administration of
Taxol result in marked nephrotoxicity even when given in
medical therapeutic doses (0.6 mg/kg). The effect was also time
independent, that is to say that the drug produced its toxic ef-
fect few hours following administrations (6 h). Marked effect
was observed after 24 and 48 h most probably due to cumula-
tive effects. The changes in kidney parenchyma involved both
glomerular and tubular elements. Focal necrosis of renal tu-
bules in the form of vaculation was observed at medical dose
(0.6 mg/kg), while higher doses produced wide spread massive
damage in renal tubules and glomerular atrophy. Chen et al.
Figure 21 Electron micrograph of similar region after 1.7 mg
Taxol administration showing degenerative changes in podocytes
(arrow). Glomerular lumen is dilated and contains cells (white
arrow). The cytoplasm of one cell showed large vacuole (v)
compressing the nucleus, podocytes. Similar part of mice PCT
showing destruction of apical microvillus (white arrow) the
nucleus (N) showed irregular shape and abnormal distribution
of peripheral chromatin (star) and nucleolus (NU). Basal enfold-
ing enclosed abnormal dark stained mitochondria (M) surrounded
by light spaces. The basement membrane (BM) is irregular and
thickened.
Figure 22 Electron micrograph of distal convoluted tubule
(DCT) of control mouse kidney showing normal thickness
basement membrane (black arrow), basal enfolding and mito-
chondria (M) The nucleus (N) is large with normal peripheral
chromatin distribution. The lumen (L) is bounded by apical
cellular membrane having few microvilli.
Figure 23 Electron micrograph of DCT lining cell from mouse
treated with 1.7 mg/kg Taxol showed thickened basement mem-
brane (BM) and dark degenerated mitochondria (M) among
abnormal basal infolding. The nucleus also showed chromatin
clumps.
112 S.O. Rabah(2008) reported that Taxol induces caspase-independent cyto-
plasmic vacuolization and cell death through endoplasmic
reticulum (ER) swelling in ASTC-a-1 cells.
In high dose group (1.7 mg) at 48 h focal regions of proxi-
mal tubular cell apoptosis were observed. Proximal tubule cells
appeared dark stained and showed pyknotic nuclei. Apoptosis
was reported to be induced by different stimuli, such as death
ligands, chemotherapeutic drugs or ionizing irradiation
(Rodriguez-Antona et al., 2007). Park et al. (2004) reported
that Taxol (paclitaxel) is known to inhibit cell growth and trig-
ger signiﬁcant apoptosis in various cancer cells. Although Tax-
ol induces apoptosis of cancer cells, its exact mechanism of
action is not yet known. Salvesen (2002) reported that apopto-
sis is mediated by members of a family of cysteine proteases
known as caspases, whose activation follows characteristic
apoptotic stimuli, and whose substrates include many proteins,the limited cleavage of which causes the characteristic mor-
phology of apoptosis.
Chen et al. (2008) reported that Taxol induce apoptosis
through autolytic activation of caspases-10 and -3 thought to
be the triggering of apoptotic process in cancer cells treated
with Taxol.
Apoptosis was suggested to occur via stimulation of death
receptors FAS-associated death domain protein (FADD) or
the activation of reactive oxygen species (ROS) (Alexandre
et al., 2007). Park et al. (2004), found that in human lympho-
blastic leukemia cell line; Taxol-induced apoptosis in the hu-
man leukemia HL-60 cell line by triggered the release of
cytochrome c into the cytosol and induced Apaf-1-mediated
caspase-3 and -9 activities known to have a role in inducing cell
apoptosis (Nicholson, 1999; Audrimont et al., 2001; Assen
et al., 2004).
Electron microscopic study and histochemistry done in the
present study showed destruction of the brush border of tubule
lining cells, degeneration of nuclei and increase nuclear periph-
eral chromatin. Loss and irregularity of basal infolding and
Table 1 Effect of Taxol ‘‘MD, ID of MTD’’ on the incidence
of micro-nucleated polychromatic erythrocytes ‘‘MN-PCEs’’ in
bone marrow of male mice.
Treatments Number of micronucleus (MN)
Time (h)
6 C 6.70 c ± 1.88
24 B 22.48 b ± 14.92
48 A 60.03 a ± 35.30
LSD at a 0.05 2.14
LSD at a 0.01 2.86
Conc.
Control D 3.96 d ± 0.73
0.60 C 32.87 c ± 30.52
1.15 A 43.20 a ± 40.11
B 38.93 b ± 24.38
LSD at a 0.05 2.47
LSD at a 0.01 3.30
Interaction
6 h · control GH 4.60 h ± 0.28
6 h · 0.60 GH 6.80 gh ± 0.84
6 h · 1.15 GH 6.40 gh ± 1.14
6 h · G 9.00 g ± 1.58
24 h · control H 3.13 h ± 0.03
24 h · 0.60 F 17.80 f ± 1.48
24 h · 1.15 E 26.80 e ± 3.42
24 h · D 42.10 d ± 6.22
48 h · control GH 4.13 h ± 0.56
48 h · 0.60 B 74.00 b ± 3.16
48 h · 1.15 A 96.40 a ± 7.23
48 h · C 65.60 c ± 4.04
LSD at a 0.05 4.28
LSD at a 0.01 5.72
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imal and distal tubules. Literature describing ultrastructure
changes on the effect of Taxol on renal tissue was lacking.
Taxol was also reported to mitochondrial stress in mela-
noma cells is mediated by activation of c-Jun N-terminal ki-
nase (JNK) and p38 pathways via uncoupling protein 2
(Selimovic et al., 2008).
Park et al. (2004) showed that Taxol decreased mitochon-
drial membrane potential (Dwm) and result in a signiﬁcant in-
crease in ROS generation. The later were known of its
damaging effect on cellular structures. In view of those reports,
the damage of mitochondria observed in ultrastructure micro-
graphs of renal tubules of mice kidney could be explained.
Mitochondria were the main source of energy supply that of
great importance for renal tubules to function in an optimum
way.
Taxol was also known to affect microtubule assembly and
stability (Chuu et al., 2007). It enhances stability of microtu-
bules, preventing the separation of chromosomes during ana-
phase. This may result in further failure of regenerative
processes important to keep integrity of kidney cellular activity
when exposed to toxic substances. Vinblastine and paclitaxel
(Taxol) are widely used chemotherapeutic drugs that inhibit
the normal function of microtubules causing mitotic arrest
and cell death (Gibb et al., 1997). Despite these similarities,the signaling pathways mediate and regulate cell death seemed
to be different (Kolomeichuk et al., 2008).
Needleman et al. (2005) reported that the cancer chemo-
therapeutic drug Taxol, suppresses microtubule dynamics
and inhibits depolymerization that ultimately result in loss of
ability of cells to regenerate if exposed to mild toxic
substances.
In an attempt to explain the mechanism by which Taxol in-
duce cytotoxicity micronucleus test was done in the present
study using bone marrow cells. It was observed that the fre-
quencies of micro-nucleated cells in bone marrow were signif-
icantly higher in Taxol treated groups in all doses.
Micronucleus formation was taken as a sign of cytotoxicity
of many drugs including Taxol (Jagetia and Adiga, 1997).
In the present study induction of micronuclei in bone mar-
row cells in vivo are in agreement with the observation of Kop-
jar et al., (2002). who reported the induction of micronuclei in
mouse bone marrow cells following Taxol administration.
Also, the present results are in agreement with investigations
on A 549 cells (Chen and Horwitz, 2002), human T. lympho-
cytes (Digue et al., 2002), and peripheral blood lymphocytes
(Bajie et al., 2007). As MNs are formed out of whole chromo-
some and Taxol found to increase signiﬁcantly the micro-
nucleated lymphocyte rates and over 85% of those micronuclei
contained one or more whole chromosomes, Taxol is said to be
aneugenic (Goodsell, 2000).
Future in vitro study using cultured renal tubular cells or
other kidney parenchymatous tissues are needed for more
understanding the mechanism by which Taxol induce cell
necrosis or apoptosis in kidney parenchyma.
In conclusion, the present light, histochemical and ultra-
structural studies together with micronucleus assay indicated
an eugenic and apoptotic potential of Taxol in mice, which
should be considered in the risk–beneﬁt analysis of its increas-
ing clinical use in human.
References
Alexandre, J., Hu, Y., Lu, W., Pelicano, H., Huang, P., 2007. Novel
action of paclitaxel against cancer cells: bystander effect mediated
by reactive oxygen species. Cancer Res. 67 (8), 3512–3517.
Assen, W., Abid-Essaﬁ, S., Achour, A., Guezzah, N., Zakhama, A.,
Ellouz, F., Creppy, E.E., Bacha, H., 2004. Karyomegaly of tubular
kidney cells in human chronic interstitial nephropathy in Tunisia:
respective role of ochratoxin. A and possible genetic predisposition.
Hum. Exp. Toxicol. 23 (7), 339–346.
Audrimont, I., Sostaric, B., Yenot, C., Betbeder, A.M., Dano-Djedje,
S., Sanni, A., Steyn, P.S., Creppy, E.E., 2001. Aspartame prevents
the karyomegaly induced by ochratoxin A in rat kidney. Arch.
Toxicol. 75 (3), 176–183.
Bajie, V., Spremo-Potparevie, B., Milieevie, Z., Zivkovie, L., 2007.
Deregulated sequential motion of centromeres induced by antitu-
mor agents may lead to genome instability in human peripheral
blood lymphocytes. J. BOUN 12, 77–83.
Chen, J.G., Horwitz, S.B., 2002. Differential mitotic responses to
microtubule-stabilizing and -destabilizing drugs. Cancer Res. 62,
1935–1938.
Chen, T.-S., Wang, X.-P., Sun, L., Wang, L.-X., Xing, D., Mok, M.,
2008. Taxol induces caspase-independent cytoplasmic vacuoliza-
tion and cell death through endoplasmic reticulum (ER) swelling in
ASTC-a-1 cells. Cancer Lett. 270 (1), 164–172.
Chuu, J.J., Liu, J.M., Tsou, M.H., Huang, C.L., Chen, C.P., Wang,
H.S., Chen, C.T., 2007. Effects of paclitaxel and doxorubicin in
114 S.O. Rabahhistocultures of hepatocelular carcinomas. J. Biomed. Sci. 14 (2),
233–244 (Epub January 6).
Crown, J., O’Leary, M., 2000. The taxanes: an update. Lancet 355,
1176–1178.
Damia, G., Broggini, M., 2004. Cell cycle checkpoint proteins and
cellular response to treatment by anticancer agents. Cell Cycle 3 (1),
46–50.
Digue, L., Orsiere, T., Baciuchka-Palmaro, M., et al., 2002. Interest of
studying the in vitro genotoxicity of an antineoplastic drug on
healthy human: paclitaxel example. Bull. Cancer 89, 887–892.
Gibb, R.K., Taylor, D.D., Dennis, M.T.W., David, L.O., Gerc¸el-
Taylor, D.C., 1997. Apoptosis as a measure of chemosensitivity to
cisplatin and Taxol therapy in ovarian cancer cell lines. Gynecol.
Oncol. 65 (1), 13–22.
Goodsell, D.S., 2000. The molecular perspective: microtubules and the
taxanes. Stem Cells 18, 382–383.
Guo, W., Zeng, C., Dong, F., Lei, W., 2002. Paclitaxel-induced
apoptosis in osteosarcoma cell line U-2 OS. Chin. Med. J. 115,
1796–1801.
Hedle, J.A., Stuart, E., Salamone, M.F., 1984. The bone marrow
micronucleus test. In Handbook of Mutagenicity Test Procedures.
Elsevier, New York, pp. 441–457.
Ikui, A.E., Yang, C.P., Matsumoto, T., Horwitz, S.B., 2005. Low
concentrations of Taxol cause mitotic delay followed by premature
dissociation of p55CDC from Mad2 and BurbR1 and abrogation
of the spindle checkpoint, leading to aneuploidy. Cell Cycle 4,
1385–1388.
Jagetia, G.C., Adiga, S.K., 1997. Correlation between micronuclei
induction and cell survival in V79 cells exposed to paclitaxel
(Taxol) in conjunction with radiation. Mutat. Res./Fundam. Mol.
Mech. Mutagen. 377 (1), 105–113.
Jordan, M.A., Toso, R.J., Thrower, D., Wilson, L., 1993. Mechanism
of mitotic block and inhibition of cell proliferation by Taxol at low
concentrations. Proc. Natl. Acad. Sci. USA 90 (20), 9552–9556.
Kolomeichuk, Sergey N., Terrano, David T., Lyle, Christopher S.,
Sabapathy, Kanaga, Chambers, Timothy C., 2008. Distinct
signaling pathways of microtubule inhibitors – vinblastine and
Taxol induce JNK-dependent cell death but through AP-1-depen-
dent and AP-1-independent mechanisms, respectively. FEBS 275
(8), 1889–1899.
Kopjar, N., Garaj-Vrhovac, V., Milas, I., 2002. Acute cytogenetic
effects of antineoplastic drugs on peripheral blood lymphocytes in
cancer patients chromosome aberrations and micronuclei. Tumori
88 (4), 300–312.
Kubota, I., Matsuzaki, S.W., Hoshiya, Y., 1997. Antitumour activity
of pactilaxel against human breast carcinoma xenografts serially
transplanted into nude mice. J. Surg. Oncol. 64, 115–121.Matter, B., Schmid, W., 1971. Trenimon-induced chromosomal
damage in bone-marrow cells of six mammalian species, evaluated
by the micronucleus test. Mutat Res. 12 (4), 417–425.
Merouani, A., Davidson, S.A., Schrier, R.W., 1997. Increased neph-
rotoxicity of combination Taxol and cisplatin chemotherapy in
gynecologic cancers as compared to cisplatin alone. Am. J.
Nephrol. 17, 53, –Perry (2001).
Needleman, D.J., Ojeda-Lopez, M.A., Raviv, U., Ewert, K., Miller,
H.P., Wilson, L., Saﬁnya, C.R., 2005. Radial compression of
microtubules and the mechanism of action of Taxol and associated
proteins. Biophys. J. 89 (5), 3410–3423.
Nicholson, D.W., 1999. Caspase structure, proteolytic substrates, and
function during apoptotic cell death. Cell Death Differ. 6 (11),
1028–1042.
Park, S.-J., Wu, c.-H., Gordon, j.D., Zhong, X., Emami, A., Safa,
A.R., 2004. Taxol induces caspase-10-dependent apoptosis. J. Biol.
Chem. 279, 51057–51067.
Rodriguez-Antona, C., Niemi, M., Backman, J.T., Kajosaari, L.I.,
Neuvonen, P.J., Robledo, M., Ingelman-Sundberg, M., 2007.
Characterization of novel CYP2C8 haplotypes and their contribu-
tion to paclitaxel and repaglinide metabolism. Pharmacogenomics
J..
Salvesen, G.S., 2002. Caspases and apoptosis. Essays Biochem. 38, 9–
19.
Schiff, P.B., Horwitz, S.B., 1981. Taxol assembles tubulin in the
absence of exogenous guanosine 5’-triphosphate or microtubule-
associated proteins. Biochemistry 20 (11), 3247–3252.
Selimovic, D., Hassan, M., Haikel, Y., Hengge, U.R., 2008. Taxol-
induced mitochondrial stress in melanoma cells is mediated by
activation of c-Jun N-terminal kinase (JNK) and p38 pathways via
uncoupling protein 2. Cell. Signal. 20 (2), 311–322.
Sorger, P.K., Dobles, M., Tournebize, R., Hyman, A.A., 1997.
Coupling cell division and cell death to microtubule dynamics.
Curr. Opin. Cell Biol. 9, 807–814.
Tresukosol, A.P., Kudelka, C.L., Edwards, C., Charnsangavej, N.,
Narboni, J., 1995. Recurrent ovarian granulosa cell tumor: a case
report of a dramatic response to Taxol international. J. Gynecol.
Cancer 5 (2), 156–159.
Wang, J., Li, Guiling, Lu, Huaying, Zheng, Zhonghui, Huang,
Yaojian, Su, Wenjin, 2000. Taxol from Tubercularia sp, strain
TF5, an endophytic fungus of Taxus mairei. FEMS Microbiol.
Lett. 193 (2), 249–253.
Zhou, B.B., Anderson, H.J., Roberge, M., 2003. Targeting DNA
checkpoint kinases in cancer therapy. Cancer Biol. Ther. 2 (4
Suppl. 1), S16–S22.
